Nearly one million cancer cases have been neglected across Europe due to the pandemic according to the European Cancer Organisation. In the US, the National Cancer Institute documented that nearly ten million cancer screenings were missed nationwide during the coronavirus outbreak. Due to ignored appointments and cancer screenings, Covid-19 will therefore, unfortunately, cause indirect increases…
Microsoft just announced the acquisition of medical artificial intelligence software maker Nuance in a deal worth $19.7bn, that represents a 23% premium to the last closing price. Nuance, one of our Digital Health portfolio companies, is focused on speech recognition software that allows physicians to capture patient discussions and enter the data into electronic health…
There’s definitely a lot of excitement around liquid biopsies and genomic testing, as illustrated by the acquisition announced today of Thrive Earlier Detection for up to $2.15bn by Exact Sciences. This transaction follows the $8bn purchase of Grail by Illumina a few weeks ago and that of ArcherDx by Invitae for up to $1.4bn in June.…
In early July, we commented that Livongo was arguably one of the most attractive assets in the Digital Health and Nutrition Tech space and was likely to attract takeover interest. Well, we didn’t have to wait long to see some M&A action as Livongo and leading telemedicine player Teladoc announced their merger today in a…
Bucking the market trend, our largest Digital Health position Teladoc reached a new high yesterday. How to fight the spread of novel infectious diseases such as the coronavirus? That’s the question health authorities across the world have had to answer in recent weeks and it appears that new technologies, namely telemedicine and medical robotics, can…